Development and Validation of Spectrophotometric Method for the Estimation of Upadaticinib in Bulk and Pharmaceutical Dosage Form

https://doi.org/10.61096/ijpir.v16.iss4.2026.1083-1091

Authors

  • Mulukuntla Lahari Research students, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed) Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Malothu Ramya Sri Research students, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed) Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Sriram Lahari Research students, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed) Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Rafya Sultana Research students, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed) Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Kummari Akhil Varun Research students, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed) Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Neelima kudumula Professor, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed), Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.
  • Duddagi Suchitra Associate Professor, Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Mahavidyalaya (Co-Ed), Affiliated to Osmania University, Tarnaka, Hyderabad, Telangana, India.

Keywords:

Upadacitinib, UV spectrophotometric method, Validation.

Abstract

Upadacitinib is a selective Janus kinase (JAK1) inhibitor used in the management of rheumatoid arthritis and other inflammatory conditions. The present study aims to develop and validate a simple, precise, and economical UV spectroscopic method for the quantitative estimation of Upadacitinib in bulk and pharmaceutical dosage forms. Upadacitinib exhibited maximum absorbance (λmax) at 233nm when scanned in the UV region using methanol as the solvent.

The method obeyed Beer-Lambert’s law in the concentration range of 2–10 µg/mL, with a correlation coefficient (R² = 0.9991), indicating excellent linearity. The developed method was validated in accordance with International Council for Harmonisation guidelines. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.39 µg/mL and 1.17 µg/mL, respectively, demonstrating good sensitivity.

The precision of the method was confirmed with %RSD values of less than 2% for both intra-day and inter-day studies. The accuracy, determined by recovery studies at 50%, 100%, and 150% levels, ranged between 98.5% and 101.2%, indicating the reliability of the method. The method showed good reproducibility and no significant interference from excipients present in the formulation.

The proposed UV spectroscopic method is simple, sensitive, accurate, and cost-effective, making it suitable for routine quality control analysis of Upadacitinib in bulk and pharmaceutical dosage forms.

Dimensions

Published

2026-11-13

How to Cite

1.
Mulukuntla Lahari, Malothu Ramya Sri, Sriram Lahari, Rafya Sultana, Kummari Akhil Varun, Neelima kudumula, et al. Development and Validation of Spectrophotometric Method for the Estimation of Upadaticinib in Bulk and Pharmaceutical Dosage Form. Int J Pharm Ind Res [Internet]. 2026 Nov. 13 [cited 2026 Nov. 17];16(4):1083-91. Available from: https://www.ijpir.com/index.php/ijpir/article/view/834

Issue

Section

Articles